Hepatitis C Virus (HCV) Vertical Transmission in 12-Month-Old Infants Born to HCV-Infected Women and Assessment of

Ravi Jhaveri1, Mohamed Hashem2, Samer S El-Kamary2

  • 1Division of Infectious Diseases, Department of Pediatrics , University of North Carolina at Chapel Hill School of Medicine.

Insights

Hepatitis C virus (HCV) vertical transmission (VT) in infants occurred at a 14.3% rate in Egypt. Maternal risk factors did not predict transmission, highlighting the need for better identification strategies and earlier infant testing.

Area of Science:

  • Hepatology
  • Virology
  • Pediatric Infectious Diseases

Background:

  • Hepatitis C virus (HCV) is a significant cause of pediatric liver disease, primarily transmitted from mother to child (vertical transmission).
  • Current infant screening guidelines for HCV are based on older testing methods, necessitating updated data with real-time PCR (polymerase chain reaction).
  • Previous studies reported HCV vertical transmission (VT) rates between 4%-15%, often linked to high maternal viral load.

Purpose of the Study:

  • To evaluate HCV RNA in infants born to viremic mothers in Egypt.
  • To assess maternal risk factors, including viral load, delivery mode, and IL28B genotype, associated with HCV vertical transmission (VT).
  • To determine the 12-month HCV VT rate in a prospective cohort in Cairo, Egypt.

Main Methods:

  • Prospective screening of pregnant women for HCV from December 2012 to March 2014.
  • Testing of infants at 12 months of age for HCV RNA using real-time PCR if the mother was viremic.
  • Analysis of maternal HCV RNA levels, mode of delivery, and IL28B genotype as potential risk factors for VT.

Main Results:

  • A total of 54 out of 2514 pregnant women (2.1%) were viremic for HCV.
  • Of 51 infants tested at 12 months, 7 were viremic, resulting in an HCV vertical transmission (VT) rate of 14.3% (7 of 49).
  • No significant association was found between maternal risk factors (viral load, delivery mode, IL28B genotype) and HCV transmission to infants.

Conclusions:

  • The study identified a 12-month HCV vertical transmission (VT) rate of 14.3% in Egypt, a region with high HCV endemicity.
  • Maternal risk factors did not reliably predict HCV transmission, indicating a need for improved predictive methods.
  • Further research should focus on identifying pregnant women at higher risk for VT and implementing earlier infant testing to detect potential chronicity.

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
30
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
42
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
38